Lage P, Cravo M, Sousa R, Chaves P, Salazar M, Fonseca R, Claro I, Suspiro A, Rodrigues P, Raposo H, Fidalgo P, Nobre-Leitão C
Instituto Português de Oncologia Francisco Gentil, CRL, SA, Rua Prof. Lima Basto, 1099-023 Lisbon, Portugal.
Am J Gastroenterol. 2004 Sep;99(9):1779-84. doi: 10.1111/j.1572-0241.2004.30178.x.
Hyperplastic polyposis (HP) is a rare condition characterized by the presence of multiple hyperplastic polyps in the colon, which has been associated to an increased risk of colorectal cancer (CRC). Guidelines for management of this disease remain, so far, undefined.
To evaluate, in symptomatic patients with HP, phenotypic characteristics as well as results of a screening program in their at-risk first-degree relatives.
Pedigree information and clinical and endoscopic data of 14 patients with HP was studied. SEVENTEEN AND METHODS: at-risk first-degree relatives from six families were also invited to perform screening colonoscopy.
Twelve of fourteen (86%) patients had fewer than 100 colorectal polyps. Polyps' sizes ranged from 2 to 25 mm and were uniformly distributed through the whole colon in 43% of the patients. Hyperplastic polyps predominated, but 11/14 (79%) patients also harbored serrated as well as classic adenomatous polyps. CRC was present in 6/14 (43%) of the patients at the time of diagnosis. Familial history of CRC/polyps was positive in 6/12 (50%) of cases. Colonoscopy in at-risk relatives disclosed polyps in 10/17 (59%) of cases with at least one additional patient having criteria for HP.
Although small, this series demonstrates that a high level of suspicion is needed to diagnose the HP syndrome, in which serrated adenomas seem to be the hallmark. Although an elevated percentage of CRC was observed in this series of symptomatic patients with HP, prospective studies in asymptomatic individuals are needed to clearly quantify the risk of CRC in patients with HP. Because familial aggregation of HP was present in 3/12 (25%) of kindreds, screening colonoscopy should be offered to first-degree relatives.
增生性息肉病(HP)是一种罕见疾病,其特征为结肠内存在多个增生性息肉,这与结直肠癌(CRC)风险增加相关。迄今为止,该疾病的管理指南仍未明确。
评估有症状的HP患者的表型特征及其高危一级亲属的筛查项目结果。
研究了14例HP患者的家系信息、临床和内镜数据。还邀请了6个家庭的高危一级亲属进行结肠镜筛查。
14例患者中有12例(86%)的结直肠息肉少于100个。息肉大小在2至25毫米之间,43%的患者息肉在整个结肠均匀分布。增生性息肉占主导,但11/14(79%)的患者还伴有锯齿状息肉以及经典腺瘤性息肉。诊断时,6/14(43%)的患者患有CRC。6/12(50%)的病例有CRC/息肉家族史。对高危亲属进行的结肠镜检查发现,10/17(59%)的病例有息肉,至少还有1例患者符合HP标准。
尽管本系列病例数量较少,但表明诊断HP综合征需要高度怀疑,其中锯齿状腺瘤似乎是其标志。虽然在这组有症状的HP患者中观察到CRC比例升高,但需要对无症状个体进行前瞻性研究,以明确量化HP患者的CRC风险。由于12个家族中有3个(25%)存在HP家族聚集现象,应向一级亲属提供结肠镜筛查。